Rapid Screening and Identification of Novel Psychoactive Substances
Staying on top of testing for novel psychoactive substances or “designer drugs” is like looking for a needle in a haystack when the needle is also a moving target. Synthetic analogs are produced faster than new methods can be developed, and sometimes compounds of interest are present in samples in very low concentrations. Agilent’s latest advances in chromatography and high-resolution accurate mass spectrometry provide designer drug testing solutions that provide screening and confirmation in a single run.
For Forensic Use